KEY WORD 1999-2000 高血圧

出版社： 先端医学社
著者：
発行日： 1999-02-25
分野： 臨床医学：内科  >  血管
ISBN： 9784915892752
電子書籍版： 1999-02-25 （第1版第1刷）
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,475 円(税込)

購入する

商品紹介

「KYE WORD 循環系」の初版が刊行されたのは1993年12月のことであった。その後数年の循環器学領域の著しい発展の結果、循環系1冊に100余のKEY WORDを盛り込むには器があまりにも小さすぎることになった。そこで循環系を「高血圧」と「高脂血症」、「心臓病」の3冊に細分して、それぞれ新たな編集者を加えて刊行することを企画した。(序文より)

目次

  • 表紙
  • 1999 - 2000年版 第3版序
  • 1994 - '95年版 初版序
  • 執筆者一覧
  • 略語一覧
  • 目次
  • あ行 圧受容体反射
  • アデノシン
  • アデュシン
  • アドレノメデュリン / アドレノメデュリン受容体
  • アネキシン
  • アポトーシス
  • アラキドン酸カスケード
  • アンジオテンシノゲン遺伝子
  • アンジオテンシンII受容体
  • アンジオテンシンII受容体拮抗薬
  • アンジオテンシン変換酵素遺伝子多型
  • 一酸化窒素
  • 一酸化窒素合成酵素
  • 遺伝子治療
  • イノシトールリン脂質代謝
  • インスリン感受性増強薬
  • インスリン抵抗性症候群
  • 運動療法
  • ABPM
  • エンドセリン受容体
  • エンドセリン受容体拮抗薬
  • エンドセリンファミリー
  • エンドセリン変換酵素と阻害薬
  • か行 カスペースファミリー
  • カテコールアミン受容体
  • カリウムチャネルオープナーと過分極弛緩連関
  • カルシウム関連遺伝子
  • Ca拮抗薬の功罪
  • カルシウム結合蛋白質
  • カルシウムチャネル
  • カルジオトロピン-1
  • カルシトニン遺伝子関連ペプチド
  • カルデスモン
  • カルパイン
  • カルポニン
  • カルモデュリン
  • カルモデュリン依存性プロテインキナーゼ
  • 冠血流予備能
  • γ-アミノ酪酸
  • キマーゼ
  • 筋小胞体
  • 血管運動中枢
  • 血管拡張神経
  • 血管新生
  • 血管内皮細胞
  • 血管内皮細胞接着分子
  • 血管内皮由来過分極因子
  • 血管内皮由来弛緩因子
  • 血管内皮由来収縮因子
  • 血管平滑筋収縮蛋白質
  • 血管リモデリング
  • 血小板由来成長因子と受容体
  • 交感神経受容体
  • 高血圧遺伝子 (ヒト)
  • 高血圧遺伝子 (ラット)
  • 高血圧自然発症ラット
  • 抗血小板薬
  • コルチゾル誘発性高血圧
  • さ行 サイクリックAMP依存性プロテインキナーゼ
  • サイクリックGMPカスケード
  • 細胞膜イオン輸送系
  • J (U) 型曲線
  • 糸球体高血圧
  • GTP結合蛋白質
  • 食塩感受性
  • 食後低血圧
  • 心筋リモデリング
  • 心拍変動のスペクトル解析
  • 心房性ナトリウム利尿ペプチド作用増強薬
  • ずり応力
  • セロトニン受容体拮抗薬
  • 線維芽細胞増殖因子
  • 側脳室周囲高信号域
  • 組織・アンジオテンシン産生系
  • た行 WHO専門委員会報告 (1996)
  • Dahlラット
  • TGF-β
  • ディッパー / ノン・ディッパー
  • T/P比
  • デコイ型核酸医薬
  • トロポニンT
  • な行 内因性ジギタリス様因子
  • ナトリウム利尿ペプチド受容体
  • ナトリウム利尿ペプチドファミリー
  • NIPPON DATA
  • ニューロペプチドY
  • 尿細管糸球体フィードバック
  • は行 白衣性高血圧
  • バゾプレッシン受容体とアンタゴニスト
  • Fas抗原 / Fasリガンド
  • フリーラジカル / 活性酸素
  • プロスタサイクリン
  • プロテインキナーゼC
  • ま行 MAPキナーゼカスケード
  • ミオシン軽鎖キナーゼ
  • 無症候性脳虚血
  • モーニングサージ
  • ら行 レニン・アンジオテンシン系ノックアウトマウス
  • 老年者高血圧長期治療試験
  • 索引
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

あ行 圧受容体反射

P.11 掲載の参考文献
1) Kumada M, Terui N, Kuwaki T et al:Arterial baroreceptor reflex:its central and peripheral neural mechanisms. Prog Neurobiol 35:331-361, 1990
PubMed
2) Robertson D, Biaggioni I:Disorders of the Autonomic Nervous System. Harwood Academic Publ, Australia, 1995, pp. 257-270
 
3) Eckberg DL, Sleight P:Human Baroreflexes in Health and Disease. Clarendon Press, Oxford, 1992, pp. 327-345
 
P.13 掲載の参考文献
1) Berne RM:The role of adenosine in regulation of coronary blood flow (brief review). Circ Res 47:807-813, 1980
 
2) Hori M, Kitakaze M:Adenosine, the heart and coronary circulation (brief review). Hypertension 18:565-574, 1991
 
3) Kitakaze M, Hori M, Kamada T:The role of adenosine and its interaction with alpha-adrenoceptor activity in myocardial ischemic and reperfusion injury (brief review). Cardiovasc Res 27:18-27, 1993
 
P.15 掲載の参考文献
1) Takakuwa Y et al:Structure of erythrocyte membrane skeleton. Nippon Rinsho 54:2341-2347, 1996
PubMed
2) Shimizu T et al:Nonerythroid membrane skeletal proteins in normal and diseased human skin. Histol Histopathol 11:495-501, 1996
PubMed
3) Bennett V:The spectrin-actin junction of erythrocyte membrane skeletons. Biochem Biophys Acta 988:107-121, 1989
PubMed
P.17 掲載の参考文献
1) Kitamura K, Eto T:Adrenomedullin-physiological regulator of the cardiovascular system or biochemical curiosity? Curr Opin Nephrol Hypertens 6:80-87, 1997
 
2) Kitamura K, Kangawa K, Kawamoto M et al:Adrenomedullin:a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560, 1993
PubMed
3) McLatchie LM, Fraser NJ, Main MJ et al:RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339, 1998
PubMed
P.19 掲載の参考文献
1) Cronpton MR, Moss SE, Crumpton MJ:Diversity in the lipocortin/calpactin family. Cell 55:1-3, 1998
 
2) Klee CB:Ca2+-dependent phospholipid- (and membrane-) binding proteins. Biochemistry 27:6645-6653, 1988
PubMed
3) Benz J, Hofmann A:Annexin:from structure to function. Biol Chem 378:177-183, 1997
PubMed
P.21 掲載の参考文献
1) Kerr JFR, Wyllie AH, Currie AR:Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972
 
2) Tanuma S:Molecular mechanisms of apoptosis. In:Apoptosis in Normal Development and Cancer. ed by Sluyser M, Taylor & Francis, London, 1996, pp. 39-59
 
3) White E:Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15, 1996
PubMed
4) Hale AJ, Smith CA, Sutherland LC et al:Apoptosis:molecular regulation of cell death. Eur J Biochem 236:1-26, 1996
PubMed
P.23 掲載の参考文献
1) 鹿取信, 山本尚三, 佐藤和雄, 阿部圭志:プロスタグランジン-最近の研究の進歩. 講談社, 東京, 1987
 
2) Yamamoto S, Smith WL(eds) :Molecular biology of the arachidonate cascade. J Lipid Mediat and Cell Signal 12, Nos. 2, 3, 1995
 
3) 尾股健, 阿部圭志:プロスタグランジンと関連物質. 日本臨牀 50:309-317, 1992
 
4) Negishi M, Sugimoto Y, Ichikawa A:Molecular mechanism of diverse actions of prostanoid receptors. Biochim Biophys Acta 1259:109-120, 1995
PubMed
P.25 掲載の参考文献
1) Jeunemaitre X et al:Molecular basis of human hypertension:role of angiotensinogen. Cell 71:169-180, 1992
PubMed
2) Russ AP et al:Rapid detection of the hypertension-associated Met 235--> The allele of the human angiotensinogen gene. Hum Mol Genet 2:609-610, 1993
 
3) Yanai K et al:Molecular variation of the human angiotensinogen core promoter element located between TATAbox and transcription initiation site affects its transcriptional activity. J Biol Chem 272:30558-30562, 1997
 
4) Inoue I et al:A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797, 1997
PubMed
5) Sato N et al:Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension. Hypertension 30:321-325, 1997
PubMed
P.27 掲載の参考文献
1) Bottari SP et al:Angiotensin II receptor subtypes:characterization, signalling mechanisms and possible physiological implications. Front Neuroendocrinol 14:123-171, 1993
PubMed
P.29 掲載の参考文献
1) The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatrnent of High Blood Pressure. Arch Intern Med 157:2413-2446, 1997
 
2) Johnston CI:Angiotensin receptor antagonists:focus on losartan. Lancet 346:1403-1407, 1995
PubMed
3) Goa KL, Wagstaff AJ:Losartan potassium. A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 51:820-845, 1996
PubMed
P.31 掲載の参考文献
1) Villard E et al:Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 58:1268-1278, 1996
PubMed
2) Rigat B et al:An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
PubMed
3) Lindpaintner K et al:A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711, 1995
PubMed
4) Cambien F et al:Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
PubMed
P.33 掲載の参考文献
1) Furchgott RF, Zawadzki JV:The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980
PubMed
2) Moncada S, Palmer RMJ, Higgs EA:Nitric oxide:physiology, pathophysiology, and Pharmacology. Pharmacol Rev 43:109-142, 1991
 
3) Toda N, Okamura T:Nitroxidergic nerve:regulation of vascular tone and blood flow in the brain. J Hypertens 14:423-434, 1996
 
P.35 掲載の参考文献
1) Moncada S, Higgs A:The l-arginine-nitric oxide pathway. New Engl J Med 329:2002-2012, 1993
 
2) 平田結喜緒 (編):NOのすべて. 医学のあゆみ (別冊), 1-286, 1996
 
P.37 掲載の参考文献
1) Phillips IM:Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29:177-187, 1997
 
2) Dzau VJ, Gibbons GH, Morishita R, Pratt E:New perspectives in hypertension research:potentials of vascular biology. Hypertension 23:1132-1140, 1994
 
3) Morishita R, Higaki J, Aoki M et al:Novel strategy of gene therapy in cardiovascular disease with HVJ-liposome method. In:Progression of Chronic Renal Diseases, ed by Koide H, Contribution to Nephrology 118, 1996, pp. 254-264
 
P.39 掲載の参考文献
1) Divecha N et al:Phospholipid signaling. Cell 80:269-278, 1995
PubMed
2) Toker A et al:Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676, 1997
PubMed
3) Hinchliffe K et al:Inositol lipid pathways turn turtle. Nature 390:123-124, 1997
PubMed
4) Camilli PD et al:Phosphoinositides as regulators in membrane traffic. Science 271:1533-1539, 1996
 
P.41 掲載の参考文献
1) Lehmann JM et al:On antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (RRARγ). J Biol Chem 270:12953, 1995
 
2) 小坂樹徳ほか:新しい経口血糖降下薬CS-O45のインスリン非依存糖尿病患者に対する単独投与における臨床評価-プラセボを対照薬とした二重盲検比較試験-. 臨床医薬9 (Suppl 3):61-94, 1993
 
3) 小坂樹徳ほか:新しい経口血糖降下剤CS-O45のインスリン非依存糖尿病患者に対するSU剤併用投与における臨床評価-プラセボを対照薬とした二重盲検比較試験-. 臨床医薬9 (Suppl 3):95-126, 1993
 
4) 小坂樹徳ほか:インスリン依存あるいはインスリン非依存糖尿病患者に対する経口血糖降下薬CS-045のインスリンとの併用投与における臨床評価-プラセボを対照薬とした二重盲検比較試験-. 医学のあゆみ 179:951-979, 199
 
5) 門脇孝:インスリン抵抗性改善薬. 日病薬誌 32:61-70, 1996.
 
6) Ogihara T et al:Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 8:316, 1995
PubMed
7) Forman BM et at:15-deoxy△12, 14 prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ. Cell 83:803, 1995
 
P.43 掲載の参考文献
1) Reaven GM:Diabetes 37:1595-1607, 1988
PubMed
2) Kaplan NM:Arch lntern Med 149:1514-1520, 1989
PubMed
3) DeFronzo RA Ferrannini:Diabetes Care 14:173-194, 1991
PubMed
4) Zimmet PZ:Diadetes Care 15:232, 1992
 
5) Matsuzawa Y et al:Metabolism 36:54, 1987
PubMed
P.45 掲載の参考文献
1) Arakawa K:Effect of exercise on hypertension and associated complications. Hypertens Res 19 (Suppl I ):S87-S91, 1996
 
2) Arakawa K:Serine protease angiotensin II systems. J Hypertens (Suppl 5):S3-S7, 1996
PubMed
P.47 掲載の参考文献
1) 今井潤:ABPの評価法. 臨床高血圧3:251-259, 1997
 
2) 苅尾七臣, 星出聡, 島田和幸:血圧日内変動と降圧療法. 循環器Today 1:1107-1111, 1997
 
3) 土橋卓也, 川崎晃一:携帯型24時間血圧測定計の使用法. Heart View 1:300-305, 1997
 
P.49 掲載の参考文献
1) Levin ER:Endothelins. New Engl J Med 333:356-363, 1995
PubMed
2) Battistini B, Botting R, Warner TD:Endothelin:a knockout in London. TIPS 16:217-222, 1995
PubMed
3) Hirata Y:Endothelin peptides. Curr Opin Nephrol Hypertens 5:12-15, 1996
PubMed
P.51 掲載の参考文献
1) Levin ER:Endothelins. New Engl J Med 333:356-363, 1995
PubMed
2) Douglas SA:Clinical development of endothelin antagonists. TIPS 18:408-412, 1997
PubMed
3) Hayhes WG, Webb DJ:Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 16:1081-1098, 1998
 
P.53 掲載の参考文献
1) 柳沢正史:エンドセリンファミリ-3つのアイソペプチド遺伝子の構造と発現. 実験医学8:111-116, 1990
 
2) Rubanyi GM, Polokoff MA:Endothelins:Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415, 1994
PubMed
3) Goto K, Hama H, Kasuya Y:Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol 72:261-290, 1996
PubMed
P.55 掲載の参考文献
1) Levin ER:Endothelins. New Engl J Med 333:356-363 1995
PubMed
2) Hirata Y:Endothelin peptides. Curr Opin Nephrol Hypertens 5:12-15, 1996
PubMed
3) Battistini B, Botting R, Warner TD:Endothelin:a knockout in London. TIPS 16:217-222, 1995
PubMed

か行 カスペースファミリー

P.57 掲載の参考文献
1) Stanger BZ, Leder P, Lee T-H et al:A novel protein containing a death domain that interact with Fas/APO-1 (CD 95) in yeast and that causes cell death. Cell 81:513-523, 1995
 
2) Alnemri ES, Livingston DJ, Nicholson DW et al:Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996
PubMed
3) Martin SI, Green DR:Protease activation during apoptosis:death by thousand cuts. Cell 82:349-352, 1995
 
4) Nicholson DW, Ali A, Thrnberry NA et al:Identification and inhibition of ICE/CED-3 protease neccessary for mammalian apoptosis. Nature 76:37-43, 1995
 
P.59 掲載の参考文献
1) Gingrich JA, Caron MG:Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299-321, 1993
PubMed
2) Jose PA, Eisner GM, Drago J et al:Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 9:400-405, 1996
PubMed
3) Jose PA, Drago J, Accili D et al:Transgenic mice to study the role of dopamine receptors in cardiovascular function. Clin Exp Hypertens 19:15-25, 1997
 
P.61 掲載の参考文献
1) 柳澤輝行:カリウムチャネルと過分極弛緩連関. 日薬理言志 106:157-169, 1995
 
2) Yanagisawa T et al:The structure-activity relationship of KRN 2391 as an N-K hybrid. Cardiovasc Drug Rev 11:94-115, 1993
 
3) 柳澤輝行:血管のKチャネル PART 1:KirとKATP チャネルの分子薬理学. 血管と内皮 8:82-86, 1998
 
P.63 掲載の参考文献
1) Orlov SN, Li JM, Tremblay J et al:Genes of intracellular calcium metabolism and blood pressure control in primary hypertension. Semin Nephrol 15:569-592, 1995
PubMed
2) 大野洋一, 猿田享男:高血圧と遺伝, カルシウム関連遺伝子と高血圧血圧 4:557-562, 1997
 
P.65 掲載の参考文献
1) Furberg CD, Psaty BM:Calcium antagonists:not appropriate as first line antihypertensive agents. Am J Hypertens 9:122-125, 1996
 
2) Epstein M:Calcium antagonists:still appropriate as first line antihypertensive agents. Am J Hypertens 9:110-121, 1996
PubMed
3) Ad Hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension:effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens 15:105-115, 1997
 
P.67 掲載の参考文献
1) Gonzalez JM, Suki WN:Cell calcium and arterial blood pressure. Semin Nephrol 15 564-568, 1995
PubMed
2) 田中利男, 趙小青, 中充子:細胞内カルシウム結合蛋白質の構造と機能. Clinical Calcium 5 49-56, 1995
 
3) 田中利男, 中充子, 伊奈田宏康ほか:カルシウムイオン細胞機能調節機構. カルシウムと生命, 山口正義編, 黒船出版静岡, 1997, pp. 68-93
 
P.69 掲載の参考文献
1) Karaki H, Ozaki H, Hori M et al:Calcium movements, distribution and functions in smooth muscle. Pharmacol Rev 49:157-230, 1997
PubMed
2) 唐木英明:Ca2+ チャネルの分子生物学. Ca拮抗薬のすべて, 猿田享男ほか編, 先端医学社, 東京, 1995, pp. 360-372
 
P.71 掲載の参考文献
1) Pennica D, King KL, Shaw KJ et al:Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 92:1142-1146, 1995
PubMed
2) Wollert KC, Taga T, Saito M et al:Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. J Biol Chem 271:9535-9545, 1996
PubMed
3) Kunisada K, Hirota H, Fujio Y et al:Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp 130 in cardiac myocytes. Circulation 94:2626-2632, 1996
 
4) Sheng Z, Knowlton K, Chen J et al:Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. J Biol Chem 272:5783-5791, 1997
 
5) Pennica D, Arce V, Swanson TA et al:Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron 17:63-74, 1994
 
P.73 掲載の参考文献
1) Aiyar N et al:A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 271:11325-11329, 1996
PubMed
2) Ishida-Yamamoto A, Toyama M:Prog Neurobiol 33:335-386, 1989
 
3) Kawasaki H et al:Nature 335:164-167, 1988
PubMed
4) Kawasaki H et al:Circ Res 67:733-743, 1990
PubMed
P.75 掲載の参考文献
1) Sobue K, Sellers JR:Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 266:12115-12118, 1991
PubMed
2) Hayashi K, Yano H, Hashida T et al:Genomic structure of the human caldesmon gene. Proc Natl Acad Sci USA 89:12122-12126, 1992
PubMed
3) Yano H, Hayashi K, Momiyama T et al:Transcriptional regulation of the chicken caldesmon gene:activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J Biol Chem 270:23661-23666, 1995
PubMed
P.77 掲載の参考文献
1) 鈴木紘一:カルパインの生理機能の解明をめざして. 生化学 65:537-552, 1993
 
2) Saido T, Sorimachi H, Suzuki K:Calpain:new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8:814-822, 1994
PubMed
P.79 掲載の参考文献
1) Takahashi K, Hiwada K, Kokubu T:Vascular smooth muscle calponin, a novel troponin T-like protein. Hypertension 11:620-626, 1988
PubMed
2) Nishida W, Kitami Y, Hiwada K:cDNA cloning and mRNA expression of calponin and SM 22 in rat aorta smooth muscle cells. Gene 130:297-302, 1993
 
3) Maguchi M, Nishida W, Hiwada K:Molecular cloning and gene mapping of human basic and acidic calponins. Biochem Biophys Res Commun 217:238-244, 1995
PubMed
4) 田中利男, 三野照正, 松島聡:血管平滑筋収縮の分子機構. 血管分子生物学, 平田結喜緒編, メディカルレビュー社, 大阪 1995, pp.77-86
 
P.81 掲載の参考文献
1) 祖父江憲治, 籾山卓哉, 小畠秀人:カルモデュリン結合蛋白質の生理機能. 蛋白質 核酸 酵素43:1688-1699, 1998
 
P.83 掲載の参考文献
1) 特集Ca2+/カルモデュリン依存性プロテインキナーゼII の構造と機能. 蛋白質 核酸 酵素37, 1992
 
2) Braun AP, Schulman H:The multifunctional calcium/calmodulin dependent protein kinase:from form to function. Annu Rev Physiol 57:417-445, 1995
PubMed
3) Mayford M, Bach ME, Kandel E:CaMKII function in the nervous system explored from a genetic perspective. Cold Spring Harb Symp Quant Biol 61:219-224, 1996
PubMed
P.85 掲載の参考文献
1) Strauer BE:Concept of coronary flow reserve. J Cardiovasc Pharmacol 19 (suppl 5):S 67-S 80, 1992
 
2) Schwartzkopff B, Motz W, Frenzel H et al:Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 88:993-1003, 1993
PubMed
3) Egashira K, Suzuki S, Hirooka Y et al:Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acethylcholine and substance. P. Hypertension 25:201-206, 1995
 
P.87 掲載の参考文献
1) Dampney RAL:Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74:323-364, 1994
 
2) Takenaka K, Sasaki S, Uchida A et al:GABA-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats. Am J Hypertens 9:964-972, 1996
PubMed
3) 大熊誠太郎, 桂昌司, 廣内雅明 :GABAおよびGABA受容体. 神経精神薬理 19:167-180, 1997
 
P.89 掲載の参考文献
1) 浦田秀則, 荒川規矩男:ヒトキマーゼ. 臨床高血圧 2:19-28, 1996
 
2) Shiota N, Fukamizu A, Takai S, Okunishi H:Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J Hypertens 15:431-440,1997
 
3) Dell, Italia LJ, Meng QC, Balcells E:Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol 269:H 2065-H 2073, 1995
 
4) Nakano A, Kishi F, Minami K et al:Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol 159:1987-1992, 1997
PubMed
P.91 掲載の参考文献
1) Karaki H, Ozaki H, Hori M et al:Calcium movements, distribution and functions in smooth muscle. Pharmacol Rev 49:157-230, 1997
PubMed
2) Marks AR:Intracellular calcium-release channels:regulators of cell life and death. Am J Physiol 272:H 597-H 605, 1997
 
P.93 掲載の参考文献
1) Dickinson CJ:Control of blood pressure by the brain:vasomotor center organization. In:Neurogenic Hypertension:A synthesis and Review. Chapman and Hall Medical, London, 1991, pp. 49-82
 
2) 熊田衛:中枢神経と血圧調節-動脈圧受容器反射を中心として. 高血圧の基礎から臨床まで-, 1990年第10回高血圧シンポジウム, 増山善明監修, 診断と治療社, 東京, 1991, pp. 10-24
 
3) Dampney RAL:Functional organization of central pathway regulating the cardiovascular system. Physiol Rev 74:323-364, 1994
 
4) Sun M-K:Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol 47:157-233, 1995
PubMed
5) Guyenet PG et al:Role of medulla oblongata in generation of sympathetic and vagal outflows. In:Prog Brain Res (Vol 107), Elsevier Science BV, NY, 1996, pp. 129-144
 
6) Sun M-K:Pharmacology of reticulospinal vasomotor neurons in cardiovascular regulation. Pharmacol Rev 48:465-494, 1996
PubMed
P.95 掲載の参考文献
1) Toda N:Nitroxidergic nerves and hypertension. Hypertens Res 18:19-26, 1995
 
2) 戸田昇, 岡村富夫:神経伝達とNO. 日薬理誌100:173-182, 1992
 
3) Okamura T, Ayajiki K, Toda N:Neural mechanism of pressor action of nitric oxide synthase inhibitor in anesthetized monkeys. Hypertension 28:341-346, 1996
PubMed
P.97 掲載の参考文献
1) Hanahan D, Folkman J:Pattern and emerging mechanisms of angiogenic switch during tumorigenesis. Cell 86:353-364, 1996
PubMed
2) Risau W:Mechanism of angiogenesis. Nature 386:671-674, 1997
PubMed
3) Hanahan D:Signaling vascular morphogenesis and maintenance. Science 277:48-50, 1997
PubMed
4) Pepper MS:Manipulating angiogenesis from basic science to the bedside. Arterioscler Thromb Vasc Biol 17:605-619, 1997
 
P.99 掲載の参考文献
1) Ross R:The pathogenesis of atherosclerosis:a perspective for the 1990s. Nature 362:801-809, 1993
PubMed
2) Vallance P, Moncada S:Nitric oxide and hypertension:Physiology and pathophysiology. In:Endothelial Function in Hypertension, ed by Webb D, Vallance P, Springer-Verlag, Berlin, Heidelberg, New York, 1997, pp. 1-11
 
P.102 掲載の参考文献
1) Springer TA:Adhesion receptors of the immune system. Nature 346:425-434, 1990
PubMed
2) Butcher EC:Leukocyte-endothelial recognition:three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991
 
3) Libby P:Atheroma:more than mush. Lancet 348:S4-S7, 1996
PubMed
P.105 掲載の参考文献
1) Shimokawa H, Vanhoutte PM:Endothelium and vascular injury. In:The Handbook of Hypertension, ed by Zanchetti A, Mancia G, Elsevier Science BV, Amsterdam, 1997, pp. 1007-1068
 
2) Feletou M, Vanhoutte PM:Endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol 23:1082-1090, 1996
PubMed
3) Urakami-Harasawa L, Shimokawa H, Nakashima M et al:Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 100:2793-2799, 1997
PubMed
P.107 掲載の参考文献
1) Furchgott RF:Role of endothelium in responses of vascular smooth muscle. Circ Res 53:557-573, 1983
PubMed
2) Palmer RMJ, Ashton DS, Moncada S:Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666, 1988
 
3) Moncada S, Higgs A:Mechanisms of disease. N Engl J Med 329:2002-2012, 1993
 
P.109 掲載の参考文献
1) Shimokawa H, Vanhoutte PM:Endothelium and vascular injury. In:The Handbook of Hypertension. ed by Zanchetti A, Mancia G, Elsevier Science BV, Amsterdam, 1977, pp.1007-1068
 
2) Vanhoutte PM:Endothelial dysfunction in hypertension. J Hypertens 14 (suppl 5):S 83-S 93, 1996
 
P.111 掲載の参考文献
1) Sobue K, Sellars JR:Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin system. J Biol Chem 266:12115-12118, 1991
 
2) 池辺光男:ミオシンのリン酸化による細胞運動の制御. 実験医学 15:1167-1174, 1997
 
P.113 掲載の参考文献
1) Gibbons GH, Dzau VJ:The emerging concept of vascular remodeling. N Engl J Med 330:1431-1438, 1994
PubMed
2) Shi Y, Pieniek M, Fard A et al:Adventitial remodeling after coronary artery injury. Circulation 93:340-348, 1996
PubMed
3) Folkow B:Hypertension:pathophysiology, diagnosis, and management, ed by Laragh JH, Brenner BM, Raven Press, New York, 1990, pp. 565-581
 
P.115 掲載の参考文献
1) Heldin CH:Structural and functional studies on platelet-derived growth factor. EMBO J 11:4251-4259, 1992
PubMed
2) Dzau VJ, Gibbons GH, Cooke Jp et al:Vascular biology and medicine in the 1990s:scope, concepts, potentials and prospectives. Circulation 87:705-719, 1993
 
P.118 掲載の参考文献
1) 梅村敏, 戸谷義幸ほか:血圧調整因子-分子生物学的アプローチ カテコールアミン, ドーパミン. 日本臨牀 55:1915-1992, 1997
 
2) Graham RM et al:Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 78:737-749, 1996
PubMed
3) Mackinnon AC et al:Alpha 2-adrenoceptors:more subtypes but fewer functional defferences. TIPS 15:119-123, 1994
 
P.121 掲載の参考文献
1) 檜垣實男, 荻原俊男:高血圧の分子生物学. 臨床高血圧 3:19-36, 1997
 
2) Inoue I et al:A nucleotide substitution in the promotor of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797, 1997
 
3) 勝谷友宏, 檜垣實男, 荻原俊男:高血圧遺伝子の最新知見. Hypertension Frontier 1:33-50, 1998
 
P.123 掲載の参考文献
1) Jacob, HJ et al:Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67:213-224, 1991.
PubMed
2) St Lezin E et al:Genetic isolation of a chromosome 1 region affecting blood pressure in the spontaneously hypertensive rat. Hypertension 30:854-859, 1997.
PubMed
3) Samani, NJ et al:Analysis of quantitative trait loci for blood pressure on rat chromosomes 2 and 13. Age-related differences in effect. Hypertension 28:1118-1122, 1996.
PubMed
P.125 掲載の参考文献
1) Rubattu S et al:Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 13:429-434, 1996
 
2) Ikeda K et al:The region responsible for stroke on chromosome 4 in the stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun 229:658-662, 1996
PubMed
3) Jeffs B et al:Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 16:364-367, 1997
 
P.127 掲載の参考文献
1) Schwartz L, Lesperance J, Bourassa MG:The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty. Am Heart J 119:232-236, 1990
PubMed
2) Yasuda T, Gold H, Yaoita H et al:Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein GP II b III a antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol 16:714-722, 1990
 
3) Ross R:The pathogenesis of atherosclerosis-An update. N Engl J Med 314:488-500 1986
PubMed
P.129 掲載の参考文献
1) Stewart PM, Walker BR, Holder G et al :11β-hydroxysteroid dehydrogenase activity in Cushing's syndrome:explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 80:3617-362, 1995
 
2) Stewart PM, Krozowski ZS, Gupita A et al:Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet 347:88-91, 1996
 
3) 宮森勇:ステロイド代謝系酵素異常. 血圧 4:57-61, 1997
 
4) White PC, Mune T, Agarwal AK:11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrine Rev 18:135-156, 1997
 

さ行 サイクリックAMP依存性プロテインキナーゼ

P.131 掲載の参考文献
1) Cohen P:Signal integration at the level of protein kinase, protein kinase protein phosphatase and their substrates. TIBS 17:408-413, 1992
PubMed
2) Taylor SS:Camp-dependent protein kinase model for an enzyme family. J Biol Chem 264:8443-8446, 1989
PubMed
3) Donal AW, Scott M, Van P:Multiple pathway signal transduction by the camp-dependent protein kinase. FASEB 8:1227-1236, 1994
 
P.133 掲載の参考文献
1) Lohmann SM et al:Signal transduction by cGMP in heart:Basic Res Cardiol 86:503-514, 1991
PubMed
2) Lagnad L, Baylor DA:Calcium controls light-triggered formation of catalytically active rhodopsin. Nature 367:273-277, 1994
 
P.135 掲載の参考文献
1) Boyden PA, Jeck CD,:Ion channel function in disease. Cardiovasc Res 29:312-318, 1995
PubMed
2) Frohlich O, Karmazyn M:The Na-H exchanger revisited:an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res 36:138-148, 1997
 
3) Lopez-Nieto EC, Brenner BM:Molecular basis of inherited disorders of renal solute transport. Curr Opin Nephrol Hypertens 6:411-421, 1997
 
P.139 掲載の参考文献
1) Anderson S:Mechanisms of injury in progressive renal disease. Exp Nephrol 1:34-40, 1996
 
2) Brenner BM, Lawler EV, Mackenzie HS:The hyperfiltration theory:a paradigm shift in nephrology. Kidney Int 49:1774-1777, 1996
PubMed
3) Cortes P, Riser B, Narins RG:Glomerular hypertension and progressive renal disease:the interplay of mesangial cell stretch, cytokine formation and extracellular matrix synthesis. Contrib Nephrol 118:229-233, 1996.
PubMed
P.142 掲載の参考文献
1) 特集 受容体と疾患. 現代医療30 (1), 1998
 
2) 貝淵弘三:低分子量Gタンパク質による細胞骨格と細胞接着の制御機構. 生化学 69:16-29, 1997
 
3) Uehata M et al:Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994, 1997
PubMed
P.145 掲載の参考文献
1) Weinberger MH:Salt sensitivity of blood pressure in humans. Hypertension 27:481-490, 1996
PubMed
2) Kimura G et al:Renal mechanism of salt sensitivity in hypertension. Curr Opin Nephrol Hypertens 3:1-12, 1994
PubMed
3) 安東克之, 藤田敏郎:食塩感受性高血圧の遺伝子解析. 最新内科学大系 プログレス6 循環器疾患1, 中山書店, 東京, 1997, pp. 112-120
 
P.147 掲載の参考文献
1) Masuo K, Mikami H, Ogihara T et al:Comparisons in frequency of orthostatic hypotension and postprandial hypotension in elderly hypertensive patients between before and afer medications for hypertension. Am J Hypertens 8:127A, 1995
 
2) Jansen RWMM, Hoefnagels WHL:Hormonal mechanisms of postprandial hypertension. J Am Geriatr Soc 39:1201-1207, 1991
 
3) Masuo K, Mikami H, Ogihara T et al:Mechanisms mediating postprandial blood pressure reduction in young and elderly subjects. Am J Hypertens 9:536-544, 1996
 
P.149 掲載の参考文献
1) Jugdutt BI, Michorowski BL:Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction:a two-dimensional echocardio-graphic study. Clin Cardiol 10:641-652, 1987
 
2) Pfeffer MA, Braunwald E:Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161-1172, 1990
PubMed
3) Koren MJ, Devereux RB, Casale PN et al:Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345-352, 1991
PubMed
P.151 掲載の参考文献
1) Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology:Heart rate variability. Circulation 93:1043-1065, 1996
 
2) 桑木共之, 日下部正宏編:血圧・心電図R-R間隔変動のスペクトル解析の現状と問題点. 自律神経 34:203-224, 1997
 
3) 合原一幸, 佐光興亜ほか:特集/生命とカオス. 数理科学 381:5-72, 1995
 
4) Goldberger AL, Rigney DR, West BJ:身体の中のカオスとフラクタル. 日経サイエンス 223:57-65, 1990
 
P.153 掲載の参考文献
1) Water M, Unwin R, Nortier J et al:Enhancing endogeneous effects of natriuretic peptides:inhibitors of neutral endopeptidase (EC.3.4.24.11) and phosphodiesterase. Curr Opin Hypertens 6:468-473, 1997
 
2) Ku B, Fugini M, Emanueli C et al:The control of microvascular permiability and blood pressure by neutral endopeptidase. Nat Med 8:904-907, 1997
 
3) Ura N, Carretero OA, Erdos EG:Role of renal endopeptidase 24.11 in kinin metabolism in vitro and vivo. Kidney lnt 32:507-513, 1987
 
4) Ogata H, Ura N, Shimamoto K et al:A sensitive method for differential determination of kininase I, II and neural endopeptidase (NEP) in human urine. Adv Exp Med Biol 247B:343-348, 1989
 
5) Ura N, Shimamoto K, Satoh S et al:Renal kininase I, kininase II and neural endopeptidase 24.11 activities in patients with essential hypertension, primary aldosteronism and Cushing's syndrome. Hypertens Res 16:253-258, 1993
 
6) Ura N, Shimamoto S, Kuroda M et al:The role of kinin and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats. Clin Exp Hypertens 16:799-808, 1994
 
7) Ogihara T, Rakugi H, Masuo K et al:Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension. Am J Hypertens 7:943-947, 1994
PubMed
P.155 掲載の参考文献
1) 安藤譲二:シェアストレスと内皮細胞. メディカルレビュー社, 大阪, 1996
 
2) Ando J, Kamiya A:Blood flow and vascular endothelial cell function. Front Med Biol Eng 5:245-264, 1993
PubMed
3) Ando J, Kamiya A:Flow-dependent regulation of gene expression in vascular endothelial cells. Jpn Heart J 37:19-32, 1996
 
P.159 掲載の参考文献
1) 江本直也:FGF:その研究の歩みと名称の混乱 (新しい名称統一-についての解説) . ホルモンと臨床41:357-362, 1993
 
2) 江本直也:FGF研究の進歩. ホルモンと臨床42:919-926, 1994
 
3) 江本直也:骨系統疾患とFGF. 内分泌・糖尿病科 4:359-366, 1997
 
P.161 掲載の参考文献
1) 緒方絢, 横田丞, 小坂知也:Leuko-araiosis. Annual Review神経1997, 中外医学社, 東京, 1997, pp. 146-151
 
2) 高木繁治:脳ドックと脳血管障害. Annual Review神経 1997, 中外医学社, 東京, 1997, pp. 112-117
 
3) 小林祥泰:無症候性脳梗塞の白質病変とleuko-araiosis. 日本臨牀 (増刊) 51:897-901, 1993
 
4) Pantoni L, Garcia JH:Pathogenesis of leukoaraiosis. A review. Stroke 28:652-659, 1997
PubMed
5) 澤田徹:無症候性脳血管障害の定義と診断基準. 日医雑誌118:653-659, 1997
 
P.163 掲載の参考文献
1) Dzau VJ:Significance of the vascular reninangiotensin pathway. Hypertension 8:553-559, 1986
PubMed
2) Miyazaki M, Okunishi H, Okamura T et al:Elevated vascular angiotensin converting enzyme in chronic two-kidney, One clip hypertension in the dog J Hypertens 5:155-160, 1987
PubMed
3) Okunishi H, Miyazaki M, Toda N:Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 2:277-284, 1984
 
4) Jin D, Takai S, Siota N, Miyazaki M:Role of vascular angiotensin converting enzyme and chymase in two-kidney, one-clip hypertensive hamsters. J Hypertens 16:657-664, 1998
 
5) Takai S, Shiota N, Kobayashi S et al:Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett 412:86-90, 1997
PubMed

た行 WHO専門委員会報告 (1996)

P.165 掲載の参考文献
1) Report of a WHO Expert Committee:Hypertension control. WHO Technical Report Series 862, Word Health Organization, Geneva, 1996
 
2) Guidelines Sub-committee:1993 Guidelines for the management of mild hypertension:memorandum from a World Health Organization/International Society of Hypertension. J Hypertens 11:905-918, 1993
PubMed
3) 築山久一郎, 荻原俊男, 日和田邦男:新らしい高血圧管理指針-JNC VI (1997) の改訂点と臨床評価-. Ther Res 19:181-202, 1998
 
P.167 掲載の参考文献
1) Rapp Jp:Dahl salt-sensitive and salt-resistant rat In:Text Book Of Hypertension, ed by Swales JD Blackwell, Scientific Publications, London, 1994, pp. 465-469
 
2) Sanders PW:Salt-sensitive hypertension:lessons from animal models. Am J Kidney Dis 28:775-782, 1996
PubMed
3) Cowley AWJr:Genetic and non-genetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr 65 (suppl):587S-593S, 1997
 
P.171 掲載の参考文献
1) Smolensky MH:Chronobiology and chronotherapeutics:application to cardiovascular medicine. Am J Hypertens 9:11S-21S, 1996
PubMed
2) Zanchetti A:The role of ambulatory blood pressure monitoring in clinical practice. Am J Hypertens 10:1069-1080, 1997
PubMed
3) 大久保孝義, 今井潤:夜間の血圧. medicina 34:630-633, 1997
 
P.173 掲載の参考文献
1) Rose M, McMahon G:Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 3:151-155, 1990
 
2) O:Brien E Sheridan J, O' Malley K:Dippers and non-dippers[letter]. Lancet ii:397, 1988
 
3) Shimada K, Kawamoto A, Matsubayashi K, et al:Silent cerebrovascular disease in the elderly:Correlation with ambulatory pressure. Hypertension 16:692-699, 1990
PubMed
4) Kuwajima I, Suzuki Y, Shimosawa T et al:Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertophy. Am Heart J 123:1307-1311, 1992
 
5) Kuwajima I, Mitani K, Miyao M, et al:Cardiac implications of morning surge in blood pressure in elderly hypertensive patients:relation to arising time. Am J Hypertens 8:29-33, 1995
PubMed
6) Staessen J, Thijs L, Clement D et al:Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. J Hypertens 12:1035-1039, 1994
PubMed
P.175 掲載の参考文献
1) 森下竜一, 荻原俊男:デコイ型核酸医薬の開発と応用領域. 日本臨牀 54:2583-2590, 1996
Medical*Online
2) Tomita N et al:Strategy for functional inactivation of genes:a novel strategy for gene therapy and gene regulation analysis using transcriptional factor decoy oligonucleotides. Exp Nephrol 5:429-434, 1997
 
3) Morishita R et al:Role of transcriptional cis-elements, angiotensinogen gene-activating element, of angiotensinogen gene in blood pressure regulation. Hypertension 27:502-507, 1996
PubMed
P.177 掲載の参考文献
1) Schiaffino S, Reggiani C:Molecular diversity of myofibrillar proteins:gene regulation and functional significance. Physiol Rev 76:371-423, 1996
PubMed
2) Hamm CW, Katus HA:New biochemical markers for myocardial cell injury. Curr Opin Cardiol 10:355-360, 1995
PubMed
3) Shahzad M, Malik A, Watkins H:The molecular genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 12:295-302, 1997
 

な行 内因性ジギタリス様因子

P.179 掲載の参考文献
1) Goto A et al:Ouabain-like factor. Curr Opin Nephrol Hypertens 7:189-196, 1998
PubMed
2) Biaustein MP:Endogenous ouabain:role in the pathogenesis of hypertension. Kidney Int 49:1748-1753, 1996
 
3) Doris PA:Endogenous inhibitors of the Na, K pump. Miner Electrolyte Metab 22:303-310, 1996
 
P.181 掲載の参考文献
1) Wilkins MR Redondo J, Brown LA:The natriuretic-peptide family. Lancet 349:1307-1310, 1997
PubMed
P.184 掲載の参考文献
1) Nakao K et al:The natriuretic peptide family. Curr Opin Nephrol Hypertens 5:4-11, 1996
PubMed
2) 伊藤裕, 中尾一和:高血圧とナトリウム利尿ペプチドファミリー. 日本内科学会雑誌1:22-29, 1995
 
3) 伊藤裕, 中尾一和:ナトリウム利尿ペプチド系. 日本臨牀55:41-53, 1997
 
P.187 掲載の参考文献
1) 上島弘嗣:日本の高血圧, 世界の高血圧:国民の血圧水準の低下と循環器疾患死亡率の減少. 血圧1:78-85, 1994
 
2) 上島弘嗣, 岡山明, 早川岳人, 佐々木敏:日本の高血圧, 世界の高血圧7:自立を保つ要因-NIPPON DATAより. 血圧2:96-100, 1995
 
3) 厚生省公衆衛生局:昭和55年度循環器疾患基礎調査報告, 日本心臓財団, 東京, 1982
 
4) 循環器疾患基礎調査追跡調査委員会:脳卒中などによる寝たきり・死亡の健康危険度評価システム開発事業:「1980年循環器疾患基礎調査」追跡調査報告書. 日本循環器管理研究協議会, 東京, 1995
 
P.189 掲載の参考文献
1) Blomqvist AG, Herzog H:Y-receptor subtypes-how many more?. TINS 20:294-298, 1997
PubMed
2) 樋口宗史:神経ペプチド (NPY) の生理機能と遺伝子発現.蛋白質 核酸 酵素42:812-824, 1997
 
3) Schwartz MW, Seeley RJ:Neuroendocrine response to starvation and weight loss. N Engt J Med 336:1802-1811, 1997
 
P.191 掲載の参考文献
1) Ito S, Abe K:Tubuloglomerular feedback. Jpn Heart J 37:153-163, 1996
PubMed
2) Brannstorm K, Morsing P, Arendshorst W J:Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by Ang II and ATl receptor. Am J Physiol 39:F 749-F 755, 1996
 
3) Thorup C, Persson AEG:Impaired effect of nitric oxide synthesis inhibition on tubuloglomerular feedback in hypertensive rat Am J Physiol 40:F 246-F 252, 1996
 

は行 白衣性高血圧

P.193 掲載の参考文献
1) 今井潤, 佐久間まり子:白衣性高血圧の治療. Current therapy 13:100-105, 1995
 
2) Mancia G, Zanchetti A:White-coat hypertension:misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens 14:1049-1052, 1996
PubMed
3) National Institute of Health:The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH publication No. 98-4080, 1997
 
P.195 掲載の参考文献
1) 林松彦, 猿田享男:ADH受容体拮抗薬の臨床応用. 内分泌・代謝疾患-state of arts. 別冊・医学のあゆみ, 赤沼安夫, 藤田敏郎, 門脇孝編, 医歯薬出版, 東京, 1997, pp. 237-238
 
2) 石川三衛:バゾプレッシンV2・受容体拮抗薬. 内分泌・糖尿病科 5:483-490, 1997
 
P.197 掲載の参考文献
1) Nagata S:Apoptosis by death factor. Cell 88:355-365, 1997
PubMed
2) Yeh ET:Life and death in the cardiovascular system. Circulation 95:782-786, 1997
PubMed
P.199 掲載の参考文献
1) Kullik I et al:Transcriptional regulators of the oxidative stress response in prokaryotes and eukaryotes. Redox Report 1:23-29, 1994
PubMed
2) Nakazawa H et al:Pathological aspects of active oxygens/free radicals. Jpn J Physiol 46:15-32, 1996
PubMed
3) 福山直人, 中澤博江:NOの多面的な作用機序. 医学のあゆみ172:529-534, 1995
 
4) Barnes PJ et al:Nuclear factor-kappab:a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 10:1066-1071, 1997
 
P.201 掲載の参考文献
1) Frolich JC:Prostacyclin in hypertension. J Hypertens (Suppl 4):73-78, 1990
 
2) Vanhoutte PM:Endothelial dysfunction in hypertension. J Hyertens 14 (Suppl 5):83-93, 1996
 
P.203 掲載の参考文献
1) Nishizuka Y:The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693, 1984
PubMed
2) 黒木登志夫:Cキナーゼの多様性. 情報伝達研究の新しい展開. 実験医学 (増刊) 11:44-48, 1993
 
3) 武田忠直:細胞分子レベルからみた高血圧研究の-断章. 高血圧13:91-101, 1991
 
4) Murakawa K, Kohno M, Yasunari K et al Possible involvement of protein kinase C in the maintenance of hypertension in spontaneously hypertensive rats. J Hypertens 6 (Suppl 4):S 157-S 159, 1988
 
5) Uehara Y, Ishii M, Ishimitsu T et al:Enhanced phospholipase C activity in the vascular wall of spontaneously hypertensive rats. Hypertension 11:28-33, 1988
PubMed

ま行 MAPキナーゼカスケード

P.205 掲載の参考文献
1) Sturgill TW, Wu J:Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S 6. Biochim Biophys Acta 1092:350-357, 1991
 
2) Nishida E, Gotoh Y:The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18:128-131, 1993
PubMed
P.207 掲載の参考文献
1) Stull JT:Myosin light chain kinase In:Biochemistry of Smooth Muscle Contraction, ed by Barany M, Academic Press, 1996, pp. 119-130
 
2) Kohama K et al:Myosin light chain kinase. Trennds Pharmacol Sci 17:284-287, 1996
PubMed
3) Gallagher PJ et al:Myosin light chain kinases. J Muscle Res Cell Motil 18:1-16, 1997
PubMed
P.209 掲載の参考文献
1) 澤田徹:無症候性脳血管障害とは-その定義と診断基準-. 日内会誌86:725-732, 1997
 
2) Kario K, Matsuo T, Kobayashi H et al:'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. Arterioscler Thomb Vasc Biol 16:734-741, 1996
 
3) Kario K, Matsuo T, Kobayashi H et al:Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients :advanced silent cerebrovascular damage in extreme dippers. Hypertension 27:130-135, 1996
PubMed
4) 秋口一郎:予防と対策, 特に血圧管理について. 日内会誌86:770-774, 1997
 
5) 江口和男, 苅尾七臣, 島田和幸:高血圧性脳血管障害の治療. カレントテラピー15:1937-1942, 1997
 
P.211 掲載の参考文献
1) Kuwajima I, Mitani K, Miyao M et al:Cardiac implications of morning surge in blood pressure in elderly hypertensive patients:relation to arising time. Am J Hypertens 8:29-33, 1995
PubMed
2) Panza JA, Epstein SE, Quyyumi, AA:Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity [see comments]. N Engl J Med 325:986-990, 1991
 
3) Pickering TG, Levenstein M, Walmsley P:Nigh time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT study. Hypertension and Lipid Trial Study Group [see comments]. Am J Hypertens 7 (9 Pt 1):844-847, 1994
 

ら行 レニン・アンジオテンシン系ノックアウトマウス

P.213 掲載の参考文献
1) Fukamizu A, Murakami K:Activated and inactivated renin-angiotensin system in transgenic animals-from genes to blood pressure. Lab Anim Sci 47:127-131, 1997
PubMed
2) Matsusaka T, Ichikawa I:Biological functions of angiotensin and its receptors. Annu Rev Physiol 59:395-412, 1997
PubMed
3) Smithies O:A mouse view of hypertension. Hypertension 30:1318-1324, 1997
PubMed
P.215 掲載の参考文献
1) MacMahon S, Rodgers A:The effects of blood pressure reduction in older patients:an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 15:967-978, 1993
PubMed
2) The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 157:2413-2446, 1997
 
3) Gong L, Zhang W, Zhu Y et al:Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 14:1237-1245, 1996
 
4) Staessen JA, Fagard R Thijs L et al:For The Systohc Hypertension in Europe (Syst-Eur) Trial Investigators. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350:757-764, 1997
PubMed

書評

最近チェックした商品履歴

Loading...